ARYA Sciences Acquisition Corp II

Completed

Follow

Detailed Information

Information on this SPAC.

Sponsors: ARYA Sciences Holdings (ARYA Sciences Holdings II)
IPO Size: $125M
SEC Filings: 1805387
Public Embarc Page: https://embarc.com/capital/spac/1805387/ARYB/arya-sciences-acquisition
IPO Ticker: ARYB

SPAC Leadership

Information on the SPAC leadership.

ChairmanJoseph Edelman
Chief Executive Officer and DirectorAdam Stone
Chief Financial Officer and DirectorMichael Altman, CFA
Chief Business OfficerKonstantin Poukalov
DirectorJake Bauer
DirectorChad Robins
DirectorTodd Wider

Target Information

Information on the SPAC target for merger.

Company: Cerevel Thera
New Ticker: CERE CEREW
Description: Cerevel Therapeutics is a Boston neuroscience company that was spun out from Pfizer in 2018